Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.

Oskar Hansson, Sara Hall, Annika Ohrfelt, Henrik Zetterberg, Kaj Blennow, Lennart Minthon, Katarina Nägga, Elisabet Londos, Shiji Varghese, Nour K Majbour, Abdulmonem Al-Hayani, Omar Ma El-Agnaf

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

316 Nedladdningar (Pure)

Sammanfattning

The objective was to study whether α-synuclein oligomers are altered in the cerebrospinal fluid (CSF) of patients with dementia, including Parkinson disease with dementia (PDD), dementia with Lewy bodies (DLB), and Alzheimer disease (AD), compared with age-matched controls.
Originalspråkengelska
Artikelnummer25
TidskriftAlzheimer's Research & Therapy
Volym6
Nummer3
DOI
StatusPublished - 2014

Ämnesklassifikation (UKÄ)

  • Neurologi

Fingeravtryck

Utforska forskningsämnen för ”Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här